NVIDIA BioNeMo Agent Toolkit Brings Accelerated AI to Life Sciences Researchers in Claude Science
NVIDIA Blog · Anthony Costa · 2026-06-30
NVIDIA announces that its BioNeMo Agent Toolkit integrates with Anthropic's newly launched Claude Science AI workbench, giving life sciences researchers GPU-accelerated bioinformatics workflows — including genomic analysis, protein structure prediction, and drug discovery — accessible through natural language agents.
Appears in
Extraction
Topics: life-sciences-aidrug-discoveryagentic-aibioinformaticsanthropic-claude
Claims
- Anthropic launched Claude Science, an AI workbench that lets scientists run end-to-end research workflows through natural language conversations with domain-specialized agents.
- NVIDIA BioNeMo Agent Toolkit packages GPU-accelerated bioinformatics capabilities — including Evo 2, Boltz-2, and OpenFold3 — as callable skills that Claude Science agents can invoke.
- 18 of the top 20 pharmaceutical companies use NVIDIA BioNeMo technologies.
- RAPIDS-singlecell, developed by scverse, compresses a 1.3-million-cell preprocessing and clustering workflow from 52 minutes to 25 seconds.
- Claude Science entered public beta on June 30, 2026, with Anthropic inviting researcher feedback on additional domain specialists.
Key quotes
Claude Science lets scientists use natural language to move their research from intent into action, without manually configuring models, endpoints, or software environments.
NVIDIA BioNeMo Agent Toolkit gives scientific agents the accelerated tools they need to operate at the speed of science.
Scientists can access BioNeMo-powered workflows through Anthropic's Claude Science, which is entering public beta today.